Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SERPINA1 as a Shared Biomarker in Periodontitis and Oral Squamous Cell Carcinoma. | Int Dent J | 2026 | 41558114 | PubTator, text mining | PubMed |
| Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa. | J Invest Dermatol | 2026 | 41548865 | PubTator, text mining | PubMed |
| Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility. | Nat Commun | 2026 | 41540004 | PubTator, text mining | PubMed |
| Uncovering pleiotropic loci linking keratoconus and allergic diseases through integrative genomic analyses. | Sci Rep | 2026 | 41526633 | PubTator, text mining | PubMed |
| Targeting the undruggable transcription factor, KLF5, with a peptidomimetic small molecule, NC114, attenuates pressure overload-induced cardiac remodeling and fibrosis. | Sci Rep | 2026 | 41526530 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular basis and therapeutic advances. | Signal Transduct Target Ther | 2026 | 41526343 | PubTator, text mining | PubMed |
| Tryptophan metabolic gatekeeping in epithelial repair: GPR35-KLF5 circuitry decodes mucosal damage signals for repair programming. | Cell Death Dis | 2026 | 41513630 | PubTator, text mining | PubMed |
| KLF5 Activation Promotes Malignant Transformation to Drive Development of Lung Squamous Cell Carcinoma. | Cancer Res | 2026 | 41512183 | PubTator, text mining | PubMed |
| Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways. | J Biochem Mol Toxicol | 2026 | 41499346 | PubTator, text mining | PubMed |
| G-CSF promotes H3K27ac-modified KLF5 to activate CXCR4 expression and drive colon cancer growth and metastasis. | Eur J Med Res | 2026 | 41495850 | PubTator, text mining | PubMed |
| Age-independent and targetable transcription factor networks regulating CD8+ T cell senescence in aging humans. | Cell Rep | 2026 | 41481417 | PubTator, text mining | PubMed |
| Spatial heterogeneity of lactylation: insights into gene expression, metabolism, and lactate transport in human embryonic stem cells. | Biol Open | 2026 | 41467447 | PubTator, text mining | PubMed |
| AGEs promote the metastasis of colorectal cancer cells via centrosome amplification by KLF5-CEP57L1 axis. | J Biol Chem | 2026 | 41443421 | PubTator, text mining | PubMed |
| Ythdc1-p300-Klf5 Complex-Mediated Golgi Dysfunction Promotes Aortic Aneurysm. | Adv Sci (Weinh) | 2026 | 41317401 | PubTator, text mining | PubMed |
| The dysregulation of UPP1 incurred by METTL3 regulates the malignancy of esophageal squamous cell carcinoma in an m6A-YTHDC1-KLF5-mediated manner. | Cell Signal | 2026 | 41173378 | PubTator, text mining | PubMed |
| KLF5 Alleviates Excessive Autophagy-Induced Podocyte Injury by Enhancing ITCH-Mediated Ubiquitination of ACTR2. | Tohoku J Exp Med | 2026 | 41062301 | PubTator, text mining | PubMed |
| Potential regulators and metabolic networks of muscle fatty infiltration: genomic and radiomics investigation based on 33 300 participants. | Int J Surg | 2026 | 41056018 | PubTator, text mining | PubMed |
| Krüppel-like factor 5 transcription factor is a positive regulator of NRG-1 in human coronary artery smooth muscle cells. | Cardiovasc J Afr | 2025 | 41785062 | PubTator, text mining | PubMed |
| Neutrophil-derived extracellular vesicles in the plasma of alpha-1 antitrypsin deficient individuals reveal pro-inflammatory metabolic and transcriptomic signatures. | Extracell Vesicle | 2025 | 41613853 | PubTator, text mining | PubMed |
| Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer. | Front Immunol | 2025 | 41583492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=5